Vaxess Technologies is an innovative life sciences company based in the brand new Harvard Life Lab in Boston Massachusetts. Formed in 2012 by founders from Harvard and Tufts Universities, the company is developing proprietary technologies based on a silk biopolymer platform for encapsulating and stabilizing biological compounds.

They work with partners to develop therapeutic and diagnostic products that are highly innovative in presentation format and robust under extreme environmental conditions, such as exposure to high temperatures outside of cold chain storage and transportation.

Vaxess is made up of a diverse group of scientists, engineers, and entrepreneurs. They share a passion for developing biomedical innovations that improve healthcare products and bring them to more people.